SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is trending sharply higher after MSCI announced it will not exclude Digital Asset Treasury Companies from its global indexes, reversing earlier plans. The community is buzzing with excitement, anticipating a significant short squeeze and a "path back to normalcy" following previous delisting fears. This decision removes a major overhang, fueling discussions of a substantial rally despite some lingering caution regarding Bitcoin's volatility.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending with immense community interest due to escalating geopolitical discussions surrounding the United States' strategic interest in acquiring Greenland, which hosts CRML's significant Tanbreez rare earth project. Investors are actively discussing the potential for government involvement to secure critical rare earth supplies, driving substantial trading volume and speculation about a significant price surge. This heightened conversation reflects a broader market focus on establishing Western independence in the crucial rare earth sector.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amidst anticipation surrounding its Northern Data acquisition, which is expected to expand its cloud and GPU capabilities, potentially securing government contracts. Major investor Tether is also committing substantial funds for advertising and cloud services, coinciding with high community chatter about a looming short squeeze driven by significant short interest and the upcoming Rumble Wallet with crypto payment options.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing an explosive rally driven by intense demand for memory and storage within the rapidly expanding AI infrastructure sector, with community discussion highlighting widespread memory shortages and the stock's parabolic ascent. This significant price surge and high trading volume have ignited active debate among investors regarding the sustainability of the 'AI supercycle' and its valuation.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus (MNTS) is experiencing a surge following news of its innovative 3D-printed fuel tank, slated for flight testing on an upcoming SpaceX mission, igniting strong community interest in the aerospace sector. Investors are actively discussing its low float and high short interest, with many anticipating significant growth and comparing it to a "mini SpaceX" within the expanding space and defense industry.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending due to significant volatility following analyst downgrades from competitor banks, which many in the community perceive as market manipulation designed to acquire shares at a lower price. This sentiment is fueled by the recent completion of a public offering where underwriters exercised options to buy shares. Despite the sharp dip, long-term investors are actively 'buying the dip,' anticipating strong upcoming earnings and potential S&P 500 inclusion.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amidst heightened activity in the GLP-1 market, with upcoming J.P. Morgan conference participation and recent headlines about Novo Nordisk's oral Wegovy launching at aggressive pricing fueling community debate. Bulls strongly believe VKTX's VK2735, a dual GLP-1/GIP agonist with promising oral and injectable data, is significantly undervalued and poised for a major acquisition or substantial growth, while bears criticize management's perceived reluctance to secure a buyout and worry about escalating competition. The core tension centers on whether Viking can successfully navigate the rapidly evolving obesity and MASH landscape as an independent entity or if a strategic partnership or acquisition is inevitable, with the community actively discussing potential catalysts like regulatory feedback on oral VK2735's Phase 3 path.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is capturing significant attention with a notable surge in trading volume and social buzz, driven by strong technical performance and community anticipation. Investors are actively discussing its potential for a major price breakout, fueled by upcoming utility implementations in 2026 centered around decentralized AI, DePIN, and secure data monetization within Japan's evolving digital landscape. This optimism is balanced by some caution regarding the token's historical volatility.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending due to its recently executed agreement with the U.S. Department of Energy (DOE) for Project TETRA, a pilot reactor initiative to advance its Integral Molten Salt Reactor technology. The community views this as a significant validation, sparking comparisons to OKLO and intense discussion about IMSR's potential as a long-term player in meeting future energy demands, especially for AI infrastructure, amidst debates on its valuation and recent market performance.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is trending amid reports that Eli Lilly is in advanced talks to acquire the company for over $1 billion, igniting widespread investor discussion about the potential valuation and a significant short squeeze. The community is actively debating whether this development will spark a bidding war among other major pharmaceutical players interested in Ventyx's promising oral inflammatory-disease drug pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates

(RTTNews) - PASSAGE BIO, INC. (PASG) announced Loss for third quarter that decreased from the same period last year and beat the Street estimates...

Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet

The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

The mean of analysts' price targets for Passage Bio (PASG) points to a 1415.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Passage Bio Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

PASG
Passage Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PASG News

PASGPassage Bio Inc